1. Home
  2. LXRX vs DLNG Comparison

LXRX vs DLNG Comparison

Compare LXRX & DLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • DLNG
  • Stock Information
  • Founded
  • LXRX 1995
  • DLNG 2013
  • Country
  • LXRX United States
  • DLNG Greece
  • Employees
  • LXRX N/A
  • DLNG N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • DLNG Marine Transportation
  • Sector
  • LXRX Health Care
  • DLNG Consumer Discretionary
  • Exchange
  • LXRX Nasdaq
  • DLNG Nasdaq
  • Market Cap
  • LXRX 124.4M
  • DLNG 143.7M
  • IPO Year
  • LXRX 2000
  • DLNG 2013
  • Fundamental
  • Price
  • LXRX $0.46
  • DLNG $3.78
  • Analyst Decision
  • LXRX Buy
  • DLNG
  • Analyst Count
  • LXRX 4
  • DLNG 0
  • Target Price
  • LXRX $3.67
  • DLNG N/A
  • AVG Volume (30 Days)
  • LXRX 30.7M
  • DLNG 43.3K
  • Earning Date
  • LXRX 03-06-2025
  • DLNG 03-06-2025
  • Dividend Yield
  • LXRX N/A
  • DLNG 2.57%
  • EPS Growth
  • LXRX N/A
  • DLNG 112.55
  • EPS
  • LXRX N/A
  • DLNG 1.40
  • Revenue
  • LXRX $31,081,000.00
  • DLNG $156,403,000.00
  • Revenue This Year
  • LXRX N/A
  • DLNG N/A
  • Revenue Next Year
  • LXRX $101.91
  • DLNG $0.37
  • P/E Ratio
  • LXRX N/A
  • DLNG $2.74
  • Revenue Growth
  • LXRX 2481.48
  • DLNG N/A
  • 52 Week Low
  • LXRX $0.28
  • DLNG $2.81
  • 52 Week High
  • LXRX $2.45
  • DLNG $5.65
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 50.12
  • DLNG 37.35
  • Support Level
  • LXRX $0.32
  • DLNG $3.88
  • Resistance Level
  • LXRX $0.41
  • DLNG $3.99
  • Average True Range (ATR)
  • LXRX 0.05
  • DLNG 0.12
  • MACD
  • LXRX 0.03
  • DLNG 0.02
  • Stochastic Oscillator
  • LXRX 36.36
  • DLNG 12.94

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

About DLNG Dynagas LNG Partners LP Common Units

Dynagas LNG Partners LP is a limited partnership company focused on owning and operating high specification and versatile LNG carriers that are employed on multi-year contracts with international energy companies, providing the benefits of stable cash flows and high utilization rates. The company defines charters of two years or more as multi-year charters. Its current LNG Carrier fleet is optimized for trading flexibility. In addition to conventional trade, part of LNG Carrier fleet is assigned with Ice Class 1A FS notation and are winterized which enables trade in subzero and ice bound conditions.

Share on Social Networks: